eFFECTOR Therapeutics Inc
OTC:EFTR
eFFECTOR Therapeutics Inc
OTC:EFTR
Price:
0.0002
USD
Market Closed
Market Cap:
$940
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
eFFECTOR Therapeutics Inc
OTC:EFTR
|
US |
|
UEX Ltd
TSE:9888
|
JP |
|
Toyokumo Inc
TSE:4058
|
JP |
|
Adams PLC
LSE:ADA
|
IM |
|
CanAlaska Uranium Ltd
XTSX:CVV
|
CA |
|
CrowdStrike Holdings Inc
BMV:CRWD
|
US |
|
N
|
Northam Platinum Holdings Ltd
JSE:NPH
|
ZA |
|
Lion Rock Group Ltd
HKEX:1127
|
HK |
|
N
|
Ningbo Xusheng Auto Technology Co Ltd
SSE:603305
|
CN |
|
K
|
Ks Bancorp Inc
OTC:KSBI
|
US |
|
Aareal Bank AG
XETRA:ARL
|
DE |
|
Gateway Mining Ltd
ASX:GML
|
AU |
|
M
|
MoonLake Immunotherapeutics
NASDAQ:MLTX
|
CH |
|
J
|
John Cockerill India Ltd
BSE:500147
|
IN |
|
Brookside Energy Ltd
ASX:BRK
|
AU |
|
Easterly Government Properties Inc
NYSE:DEA
|
US |
|
S
|
Shanghai Huitong Energy Co Ltd
SSE:600605
|
CN |
|
goeasy Ltd
TSX:GSY
|
CA |
|
Build-A-Bear Workshop Inc
NYSE:BBW
|
US |
|
I
|
Iceland Seafood Internat hf
ICEX:ICESEA
|
IS |
|
T
|
Tijaria Polypipes Ltd
NSE:TIJARIA
|
IN |
|
Borosil Ltd
NSE:BOROLTD
|
IN |
|
S
|
Svenska Cellulosa SCA AB
XBER:SCA
|
SE |
|
Ban Leong Technologies Ltd
SGX:B26
|
SG |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of EFTR.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
EFTR
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
EFTR Competitors Multiples
eFFECTOR Therapeutics Inc Competitors
eFFECTOR Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
eFFECTOR Therapeutics Inc
OTC:EFTR
|
1.1m USD | 0 | -0 | 0.7 | 0.7 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD | 6 | 88.2 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.4B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD | 9.3 | 28.2 | 21.2 | 22.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD | 5.6 | 17.9 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3.1 | 34 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.3 | 40.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
